Anxiety Disorder and Depression Treatment Market Forecast To Reach USD18.90 Billion By 2026 | Pfizer, Johnson & Johnson, Inc., Lundbeck A/S, Inc., GlaxoSmithKline plc., Sanofi- Aventis

The Global Anxiety Disorder and Depression Treatment Market is forecast to reach USD18.90 Billion by 2026, according to a new report by Reports and Data. There has been a continued rise in the rate of depression and anxiety in the global healthcare scenario. Such a rise in the incidence rate of depression and anxiety has resulted in focusing on the global healthcare scenario and reduce the incidence rate of such mental healthcare condition. In the year 2018, more than 300 million individuals of all ages were suffering from depression in the global scenario. There have been 800,000 incidents of suicides in the same year, the reason behind which has been primarily, depression and anxiety disorders. Such a rise in the incidence of rate of depression and anxiety are one of the major factors driving the global Anxiety Disorder and Depression Treatment Market.

Download Sample Copy of this Report before you purchase free of cost! @ https://www.reportsanddata.com/sample-enquiry-form/1405

Companies considered and profiled in this market study

Pfizer, Johnson & Johnson, Inc., Lundbeck A/S, Inc., GlaxoSmithKline plc., Sanofi- Aventis, Merck & Company, AstraZeneca PLC., Eli Lilly, Forest Laboratories, and Company, Bristol-Myers Squibb Company.

Globally, incidences of depression and mental health are continuously increasing in the elderly population. This population is prone to mental health issues like dementia, phobia and anxiety disorders. Hence, the increase in the graying population is also contributing to the rising demand for antidepressants and therapies to treat the mental health condition during the forecast period.

In the year 2018, the global Anxiety Disorder and Depression Treatment Market was dominated by North America. This region can be forecasted to continue this domination throughout the forecast period. The reason North America dominates the market is mainly because of the rising incidence rate of anxiety disorders and depression in a particular region.

For the purpose of this report, Reports and Data have segmented the global Anxiety Disorder and Depression Treatment Market based on Drug class, Therapies, Devices, Application, End-users, and Region:

Drug class Outlook (Revenue, USD Billion; 2016-2026)
Selective Serotonin Reuptake Inhibitors (SSRIs)
Antidepressant Drugs
Tricyclic Antidepressants (TCAs)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Monoamine Oxidase Inhibitors (MAOIs)
Benzodiazepines
Atypical Antipsychotics
Anticonvulsants
Beta-Blockers
Others

Therapies Outlook (Revenue, USD Billion; 2016-2026)
Electroconvulsive Therapy (ECT)
Cognitive Behavior Therapy (CBT)
Psychotherapy
Deep Brain Stimulation
Transcranial Magnetic Stimulation (TMS)
Cranial electrotherapy stimulation (CES)

Grab Your Report at an Impressive Discount! Please Click Here @ https://www.reportsanddata.com/discount-enquiry-form/1405

Devices Outlook (Revenue, USD Billion; 2016-2026)
Cranial electrotherapy stimulator
Fisher-Wallace stimulator market

Application Outlook (Revenue, USD Billion; 2016-2026)
Phobia
Major Depressive Disorder
Obsessive Compulsive Disorder (OCD)
Post-traumatic stress disorder
Others

End-users Outlook (Revenue, USD Billion; 2016-2026)
Hospitals
Mental healthcare centers
NGOs
Asylums

Regional Outlook (Revenue, USD Billion; 2016-2026)
North America
Europe
Asia Pacific
MEA
Latin America

Further key findings from the report suggest

1. The rising rate of occurrence of depression and anxiety is one of the contributing factors for the high consumption rate of anti-depressants.

2. This rise in the occurrence rate of anxiety and depression is one of the major driving factors for global Anxiety Disorder and Depression Treatment Market, contributing to market growth.

3. In the segment Drug class, the highest market share was held by antidepressants, in the year 2018, followed by antidepressants. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) dominated the markets in the year 2018, with a market share of 28%.

4. Rise in the occurrence rate of anxiety and depression along with incidents of suicide, the edifice of which were anxiety disorders have also made a positive impact on the global Anxiety Disorder and Depression Treatment M

5. As a result of such incidents of suicide, there has been a rise in demand for therapies. In the year 2018, Cognitive Behavior Therapy [CBT] dominated the market with a market share of 30%.

6. During the forecast period, CBT is forecasted to hold a market share of 31% by 2026.

To Buy This Report, Click Here @ https://www.reportsanddata.com/checkout-form/1405

Key selling points of this research study

1. The study gives an in-depth evaluation of the evolving competitive scenario that gives the reader/client a competitive edge.

2. It offers a holistic view of all critical aspects boosting or limiting the growth of the sector

3. The market intelligence report derives an eight-year forecast, including historical, contemporary, and potential market prospects, projecting the estimated progress of the market.

4. It aids informed decision-making by offering an exhaustive database of the pivotal market segments and sub-segments.

Contact Us:

John Watson
Head of Business Development
Reports and Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.